These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35281606)

  • 1. The Therapeutic Potential of Aprepitant in Glioblastoma Cancer Cells through Redox Modification.
    Rezaei S; Assaran Darban R; Javid H; Hashemy SI
    Biomed Res Int; 2022; 2022():8540403. PubMed ID: 35281606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
    Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
    Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells.
    AlAlikhan A; Ghahremanloo A; Javid H; Ebrahimi S; Hashemy SI
    Cell Biochem Biophys; 2022 Dec; 80(4):819-827. PubMed ID: 36197642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders.
    Ebrahimi S; Alalikhan A; Aghaee-Bakhtiari SH; Hashemy SI
    Life Sci; 2022 May; 296():120448. PubMed ID: 35247438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SP/NK1R System-Mediated ROS Generation in GBM Cells through Inhibiting Glutaredoxin Protein.
    Mehrabani N; Vaezi Kakhki MR; Javid H; Ebrahimi S; Hashemy SI
    Neurol Res Int; 2021; 2021():9966000. PubMed ID: 34917417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
    Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of the SP/ NK1R system in GBM cells through inhibiting the thioredoxin system.
    Ghahremani F; Sabbaghzadeh R; Ebrahimi S; Javid H; Ghahremani J; Hashemy SI
    Iran J Basic Med Sci; 2021 Apr; 24(4):499-505. PubMed ID: 34094032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells.
    Korfi F; Javid H; Assaran Darban R; Hashemy SI
    Biochem Res Int; 2021; 2021():6620708. PubMed ID: 33976938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
    Coveñas R; Rodríguez FD; Robinson P; Muñoz M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells.
    Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38334824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant.
    Bashash D; Safaroghli-Azar A; Bayati S; Razani E; Pourbagheri-Sigaroodi A; Gharehbaghian A; Momeny M; Sanjadi M; Rezaie-Tavirani M; Ghaffari SH
    Int J Biochem Cell Biol; 2018 Oct; 103():105-114. PubMed ID: 30145367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
    Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI
    Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells.
    Golestaneh M; Firoozrai M; Javid H; Hashemy SI
    Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P and the Neurokinin-1 Receptor: The New CRF.
    Schank JR; Heilig M
    Int Rev Neurobiol; 2017; 136():151-175. PubMed ID: 29056150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
    Ohanyan T; Schoepke N; Eirefelt S; Hoey G; Koopmann W; Hawro T; Maurer M; Metz M
    Acta Derm Venereol; 2018 Jan; 98(1):26-31. PubMed ID: 28853492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative effects of [D-Pro2, D-Trp7,9]-Substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells.
    Matalińska J; Świć A; Lipiński P; Misicka A
    Folia Neuropathol; 2020; 58(3):237-244. PubMed ID: 33099293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
    Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
    Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.